Regulation & Compliance

A high-stakes legal battle unfolds as Xeris sues to block generic versions of its blockbuster Cushing's syndrome drug, Recorlev, until 2040.

A market void left by two US titans creates a massive opportunity for a French brand specializing in realistic, plant-based temporary tattoos.

Oportun celebrates a major financial turnaround and its fifth straight profitable quarter, but a closer look reveals rising delinquencies and new headwinds.

Facing user burnout and fierce rivals, Tinder's first-ever product event aims to reignite the flame. Can new tech and a new vision save the dating giant?

Over 1,500 traders have given $6.1M to AI agents in a 21-day DeFi deathmatch where only one token survives. Is this the future or financial insanity?

With millions of Canadians suffering from dry eye, a new program combines advanced tech like IPL with personalized plans to offer hope and accessible relief.

Orion's new integrated AI platform is now live, promising to unify data, automate tasks, and free advisors to focus on clients.

Variscite's new SMARC SoMs blend AI power with built-in compliance for CRA and FIPS, backed by a stable supply chain to navigate market volatility.

The Puerto Rican banking giant's latest $0.75 dividend reflects strong financials and analyst confidence, solidifying its appeal for income-focused investors.

Amid new regulations, eClinical Solutions unveils agentic AI to automate data review, streamline compliance, and accelerate breakthrough therapies.

Michigan's largest independent oncology practice adds urology, promising patients more coordinated, lower-cost care outside of traditional hospital systems.

Facing a 5-day suspension for failures tied to the Jontay Porter scandal, PointsBet Canada is claiming human error while the AGCO calls it a systemic failure.

Digital marketing agency Curious Orange poaches leaders from Google and Instrument, signaling a major trend of top talent flocking to agile indie shops.

A new report reveals a dramatic rise in employee concerns over toxic culture, safety, and AI, transforming ethics hotlines into strategic risk barometers.

GEMMABio has dosed the first infant in a trial for its next-gen SMA1 gene therapy, a new approach designed to improve safety and global access.

The legal services pioneer is shaping industry dialogue on agentic AI, ecosystem risk, and operational efficiency at a slate of major 2026 conferences.

Luna Federici, the architect of PicnicHealth's recent growth, takes the helm as President to scale the company's patient-first, AI-powered research model.

Verifiable's new CredAgent™ promises to slash credentialing times and costs, challenging the industry's reliance on manual labor and offshore outsourcing.

Panorama Education launches AI-powered tutoring and career tools, promising personalized student support while navigating the complex landscape of data privacy.

With a massive new investment led by NewSpring, physician-led Honest Health is set to expand its mission of transforming healthcare from volume to value.